General Announcement::Update on Innovative R&D Capabilities and Pipeline Overview

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
07-Jan-2019 12:58:59
Status
New
Announcement Sub Title
Update on Innovative R&D Capabilities and Pipeline Overview
Announcement Reference
SG190107OTHRHRJM
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
07/01/2019 10:30:00
Description (Please provide a detailed description of the event in the box below)
Sub: Update on Innovative R&D Capabilities and Pipeline Overview

Kindly find enclosed herewith the presentation on update on Innovative R&D Capabilities and Pipeline Overview. The same will also be made available on our website.

Request you to kindly take the same on record.

Attachments

SGX_0701.pdf
Total size =2417K